Put your innovative therapy on ClinicalTrials.gov —
without the CRO price tag.
Beacon Clinical Registry handles your observational protocol, IRB submission, ClinicalTrials.gov registration, and patient-reported outcomes — turnkey, transparent, and priced for independent practice. $2K–$7K to register; $100–$300 / month to run.
Kurve Compassionate Use Program is live.
Physicians delivering intranasal insulin or Muse cell therapy via the Kurve ViaNase Controlled Particle Dispersion® (CPD) device can enroll as observational-study sites through Beacon — FDA Form 3926, IRB concurrence, and patient onboarding handled in one electronic submission.
Seeking compassionate-use access?
Begin your secure intake here.
NFL players and their families seeking compassionate-use access to trial NCT07521384 can start a secure intake in under a minute. Register with your phone number, verify by SMS, then complete the patient portion of the request at your own pace — your treating physician is automatically invited to review and finalize FDA Form 3926.
HIPAA-shape encryption at rest. Single-use code via SMS — no password, no spam.
The evidence base for innovative medicine is sitting in your charts.
You see results every week that deserve to be in the literature. But between the protocol drafting, the IRB maze, the registration paperwork, and the publication pipeline, most practicing clinicians never get past the good-intentions stage. Beacon is the team that makes it happen.
ClinicalTrials.gov registration is free — but the protocol, IRB, and consent documents are not.
Commercial IRBs charge $500–$3,500 per review; you need someone who speaks their language.
A full EDC platform starts at $10K–$25K per study — and requires its own team to operate.
Innovative therapies generate outcomes data every day — then sit unpublished because there's no one to write the paper.
How Beacon works
Four steps from clinical observation to published evidence.
Tell us about your protocol
Ten-minute intake: your therapy, your patient population, the outcomes you care about. We shape the observational protocol around the clinical work you are already doing.
We register and get IRB coverage
We draft the protocol, submit to ClinicalTrials.gov, and coordinate IRB review through our partner board. Typical turnaround: 4–6 weeks to NCT number.
Your patients enroll and self-report
A branded enrollment portal lets patients consent electronically and complete validated questionnaires (functional status, quality of life, symptom tracking) on their phones. Data flows into your registry automatically.
You get press, papers, and proof
Post-registration press release. Monthly data summaries. Publication-ready analyses as your cohort grows. The evidence follows the patients.
Transparent, flat-fee pricing
No enterprise contracts. No per-enrollee fees. No bill-shock.
Express
Fastest path to a ClinicalTrials.gov NCT number.
Standard
Protocol polish, IRB liaison, and a real PRO program.
Full-Service
Registration, publication-readiness, and a press engine.
Your Principal Investigator
Every study registered through Beacon runs under a credentialed PI of record.
Tamara C Tamas
Founder & Principal Investigator
Biochemist and regulatory strategist with 15+ years of research experience bridging cutting-edge cellular therapies and patient care. Principal Investigator on multiple ClinicalTrials.gov-registered observational studies. Has facilitated treatment access for 200+ patients across 14 countries and now makes that same regulatory machinery available to independent clinicians.
- • MS, Biopharmaceutical Regulatory Affairs
- • BS, Chemistry (Biochemistry Focus)
- • cGMP Cell Therapy Manufacturing & Cleanroom Operations
- • Principal Investigator — ClinicalTrials.gov (multiple active studies)
- • 200+ patients across 14 countries
Your therapy deserves to be on the record.
Fill out a ten-minute intake form. We'll come back with a scoped protocol, a quote, and a target NCT date.